Literature DB >> 31529353

Mortality and costs following extracorporeal membrane oxygenation in critically ill adults: a population-based cohort study.

Shannon M Fernando1,2, Danial Qureshi3,4,5, Peter Tanuseputro3,4,6,7,5, Eddy Fan8,9, Laveena Munshi8,10, Bram Rochwerg11,12, Robert Talarico4, Damon C Scales3,8,13,14, Daniel Brodie15, Sonny Dhanani16,17, Anne-Marie Guerguerian8,18, Sam D Shemie19,20, Kednapa Thavorn3,4,6, Kwadwo Kyeremanteng21,4,7,22.   

Abstract

PURPOSE: Extracorporeal membrane oxygenation (ECMO) is used as temporary cardiorespiratory support in critically ill patients. Little is known about population-level short- and long-term outcomes following ECMO, including healthcare use and health system cost across a wide range of sectors.
METHODS: Population-based cohort study in Ontario, Canada (October 1, 2009-March 31, 2017) of adult patients (≥ 18 years) receiving ECMO for cardiorespiratory support. We captured outcomes through linkage to health administrative databases. Primary outcome was mortality during hospitalization, as well as at 7 days, 30 days, 1 year, 2 years, and 5 years following ECMO initiation. We analyzed health system costs (in Canadian dollars) in the 1 year following the date of the index admission.
RESULTS: A total of 692 patients were included. Mean (standard deviation [SD]) age was 51.3 (16.0) years. Median (interquartile range [IQR]) time to ECMO initiation from date of admission was 2 (0-9) days. In-hospital mortality was 40.0%. Mortality at 1 year, 2 years, and 5 years was 45.1%, 49.0%, and 57.4%, respectively. Among survivors, 78.4% were discharged home, while 21.2% were discharged to continuing care. Median (IQR) total costs in the 1 year following admission among all patients were Canadian $130,157 (Canadian $58,645-Canadian $240,763), of which Canadian $91,192 (Canadian $38,507-Canadian $184,728) were attributed to inpatient care.
CONCLUSIONS: Hospital mortality among critically ill adults receiving ECMO for advanced cardiopulmonary support is relatively high, but does not markedly increase in the years following discharge. Survivors are more likely to be discharged home than to continuing care. Median costs are high, but largely reflect inpatient hospital costs, and not costs incurred following discharge.

Entities:  

Keywords:  Acute respiratory distress syndrome; Cardiac arrest; Cardiogenic shock; ECMO; Extracorporeal membrane oxygenation; Health services

Mesh:

Year:  2019        PMID: 31529353     DOI: 10.1007/s00134-019-05766-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  33 in total

1.  Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis.

Authors:  Yih-Sharng Chen; Jou-Wei Lin; Hsi-Yu Yu; Wen-Je Ko; Jih-Shuin Jerng; Wei-Tien Chang; Wen-Jone Chen; Shu-Chien Huang; Nai-Hsin Chi; Chih-Hsien Wang; Li-Chin Chen; Pi-Ru Tsai; Sheoi-Shen Wang; Juey-Jen Hwang; Fang-Yue Lin
Journal:  Lancet       Date:  2008-07-04       Impact factor: 79.321

2.  Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score.

Authors:  Matthieu Schmidt; Aidan Burrell; Lloyd Roberts; Michael Bailey; Jayne Sheldrake; Peter T Rycus; Carol Hodgson; Carlos Scheinkestel; D Jamie Cooper; Ravi R Thiagarajan; Daniel Brodie; Vincent Pellegrino; David Pilcher
Journal:  Eur Heart J       Date:  2015-06-01       Impact factor: 29.983

3.  Extracorporeal membrane oxygenation: evolving epidemiology and mortality.

Authors:  Christian Karagiannidis; Daniel Brodie; Stephan Strassmann; Erich Stoelben; Alois Philipp; Thomas Bein; Thomas Müller; Wolfram Windisch
Journal:  Intensive Care Med       Date:  2016-03-04       Impact factor: 17.440

4.  Long-Term Survival in Adults Treated With Extracorporeal Membrane Oxygenation for Respiratory Failure and Sepsis.

Authors:  Viktor von Bahr; Jan Hultman; Staffan Eksborg; Björn Frenckner; Håkan Kalzén
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

5.  Intensive care utilization following major noncardiac surgical procedures in Ontario, Canada: a population-based study.

Authors:  Angela Jerath; Andreas Laupacis; Peter C Austin; Hannah Wunsch; Duminda N Wijeysundera
Journal:  Intensive Care Med       Date:  2018-07-27       Impact factor: 17.440

Review 6.  Extracorporeal membrane oxygenation for ARDS in adults.

Authors:  Daniel Brodie; Matthew Bacchetta
Journal:  N Engl J Med       Date:  2011-11-17       Impact factor: 91.245

7.  Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock.

Authors:  Alain Combes; Pascal Leprince; Charles-Edouard Luyt; Nicolas Bonnet; Jean-Louis Trouillet; Philippe Léger; Alain Pavie; Jean Chastre
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

8.  Long-Term Outcomes After Extracorporeal Life Support for Acute Respiratory Failure.

Authors:  Michael D McDonald; Danielle K Sandsmark; Jessica A Palakshappa; Mark E Mikkelsen; Brian J Anderson; Jacob T Gutsche
Journal:  J Cardiothorac Vasc Anesth       Date:  2018-06-01       Impact factor: 2.628

9.  Long-term quality of life in patients with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation for refractory hypoxaemia.

Authors:  Carol L Hodgson; Kate Hayes; Tori Everard; Alistair Nichol; Andrew R Davies; Michael J Bailey; David V Tuxen; David J Cooper; Vin Pellegrino
Journal:  Crit Care       Date:  2012-10-19       Impact factor: 9.097

10.  Characteristics, Outcomes, and Cost Patterns of High-Cost Patients in the Intensive Care Unit.

Authors:  Peter M Reardon; Shannon M Fernando; Sasha Van Katwyk; Kednapa Thavorn; Daniel Kobewka; Peter Tanuseputro; Erin Rosenberg; Cynthia Wan; Brandi Vanderspank-Wright; Dalibor Kubelik; Rose Anne Devlin; Christopher Klinger; Kwadwo Kyeremanteng
Journal:  Crit Care Res Pract       Date:  2018-09-02
View more
  15 in total

Review 1.  Inotropes, vasopressors, and mechanical circulatory support for treatment of cardiogenic shock complicating myocardial infarction: a systematic review and network meta-analysis.

Authors:  Benjamin Hibbert; Bram Rochwerg; Shannon M Fernando; Rebecca Mathew; Behnam Sadeghirad; Daniel Brodie; Emilie P Belley-Côté; Holger Thiele; Sean van Diepen; Eddy Fan; Pietro Di Santo; Trevor Simard; Juan J Russo; Alexandre Tran; Bruno Lévy; Alain Combes
Journal:  Can J Anaesth       Date:  2022-10-04       Impact factor: 6.713

Review 2.  Management of Acute Heart Failure during an Early Phase.

Authors:  Koji Takagi; Antoine Kimmoun; Naoki Sato; Alexandre Mebazaa
Journal:  Int J Heart Fail       Date:  2020-04-17

Review 3.  Postacute Sequelae of COVID-19 Critical Illness.

Authors:  Kristin Schwab; Emily Schwitzer; Nida Qadir
Journal:  Crit Care Clin       Date:  2022-01-10       Impact factor: 3.879

4.  Are providers overconfident in predicting outcome after cardiac arrest?

Authors:  Alexis Steinberg; Clifton Callaway; Cameron Dezfulian; Jonathan Elmer
Journal:  Resuscitation       Date:  2020-06-13       Impact factor: 5.262

5.  Human factors in ECLS - A keystone for safety and quality - A narrative review for ECLS providers.

Authors:  Justyna Swol; Daniel Brodie; Anne Willers; Bishoy Zakhary; Joseph Belezzo; Zachary Shinar; Scott D Weingart; Jonathan W Haft; Roberto Lorusso; Giles J Peek
Journal:  Artif Organs       Date:  2021-11-05       Impact factor: 2.663

6.  Suicide and self-harm in adult survivors of critical illness: population based cohort study.

Authors:  Shannon M Fernando; Danial Qureshi; Manish M Sood; Michael Pugliese; Robert Talarico; Daniel T Myran; Margaret S Herridge; Dale M Needham; Bram Rochwerg; Deborah J Cook; Hannah Wunsch; Robert A Fowler; Damon C Scales; O Joseph Bienvenu; Kathryn M Rowan; Magdalena Kisilewicz; Laura H Thompson; Peter Tanuseputro; Kwadwo Kyeremanteng
Journal:  BMJ       Date:  2021-05-05

7.  Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis.

Authors:  Kollengode Ramanathan; Kiran Shekar; Ryan Ruiyang Ling; Ryan P Barbaro; Suei Nee Wong; Chuen Seng Tan; Bram Rochwerg; Shannon M Fernando; Shinhiro Takeda; Graeme MacLaren; Eddy Fan; Daniel Brodie
Journal:  Crit Care       Date:  2021-06-14       Impact factor: 9.097

Review 8.  Extracorporeal life support for adults with acute respiratory distress syndrome.

Authors:  Alain Combes; Matthieu Schmidt; Carol L Hodgson; Eddy Fan; Niall D Ferguson; John F Fraser; Samir Jaber; Antonio Pesenti; Marco Ranieri; Kathryn Rowan; Kiran Shekar; Arthur S Slutsky; Daniel Brodie
Journal:  Intensive Care Med       Date:  2020-11-02       Impact factor: 17.440

9.  Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis during extracorporeal membrane oxygenation: a propensity score-matched analysis.

Authors:  Yutaka Kondo; Hiroyuki Ohbe; Hiroki Matsui; Kiyohide Fushimi; Hiroshi Tanaka; Hideo Yasunaga
Journal:  BMJ Open       Date:  2020-09-29       Impact factor: 2.692

10.  ECMO for severe ARDS: systematic review and individual patient data meta-analysis.

Authors:  Alain Combes; Giles J Peek; David Hajage; Pollyanna Hardy; Darryl Abrams; Matthieu Schmidt; Agnès Dechartres; Diana Elbourne
Journal:  Intensive Care Med       Date:  2020-10-06       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.